Muhammad Aiman to look into inflammatory campaign materials in Semenyih [ 19m ago ]


Malindo Air Now Offers You More Bite On-board

PETALING JAYA, Feb 12 (Bernama) -- Malindo Air has ushered into the New Year by modifying their in-flight services to better accommodate the needs of their passengers.

A wider range of snacks and beverages are now available for purchase onboard its Boeing fleet. These include hot beverages such as coffee and tea, mango and orange juice, and soft drinks, among others. Hot cup noodles, red velvet cake, potato chips, Oreo, M&M’s and Kit Kat are some of the snack items being carried on-board. These items are offered at a reasonable price for the economy class passengers who wish to have other options of snacks and drinks, on top of the complimentary hot meal or hot snack and drinking water provided. Our business class passengers on the other hand continue to enjoy all these and more on a complimentary basis.

Launch of IIFL India Equity Opportunities Fund (UCITS Fund Based in Luxembourg)

MUMBAI, India, Feb 12 (Bernama) -- IIFL Asset Management (IIFL AMC) is pleased to announce the launch of its first Luxembourg domiciled UCITS Fund, IIFL India Equity Opportunities Fund (‘IIFL Fund’) by virtue of merger of Ashburton India Equity Opportunities Fund into IIFL Fund. Pursuant to this, IIFL Fund has commenced its operations with $75mn in assets under management, effective January 29, 2019, with IIFL Capital Pte. Ltd., Singapore being its Investment Manager.

Anup Maheshwari, Joint-CEO and CIO, IIFL Asset Management, said, “I am confident that Jonathan’s investment style of investing in high conviction stocks with a strong focus on quality will continue to resonate with International Investors. It is very complementary to the overall investment philosophy at IIFL AMC as well.”

Samsung Bioepis And C-Bridge Capital To Develop And Commercialize Next-Generation Biosimilars In China

  •  Agreement covers Samsung Bioepis’ third-wave biosimilar candidates SB11 and SB12, which reference LUCENTIS
    ® [1]
    (ranibizumab) and SOLIRIS
    ® [2]
    (eculizumab), respectively
  •  Partnership brings together Samsung Bioepis’ proven agile biologics development platform and C-Bridge’s strong capital resource and China healthcare expertise
  •  C-Bridge Capital forms new biopharmaceutical company, AffaMed Therapeutics, which will collaborate with Samsung Bioepis to accelerate clinical development and registration of Samsung Bioepis’ next-generation biosimilars in China.
 INCHEON, Korea, Feb 11 (Bernama) -- Samsung Bioepis Co., Ltd. today announced its expansion in mainland China through a licensing agreement with C-Bridge Capital. The agreement covers multiple biosimilar candidates from Samsung Bioepis, including third-wave biosimilar candidates SB11 and SB12, which reference LUCENTIS® (ranibizumab) and SOLIRIS® (eculizumab), respectively, as well as SB3, a biosimilar candidate referencing HERCEPTIN®[3]  (trastuzumab).  Under the agreement, C-Bridge will establish a new biopharmaceutical company, AffaMed Therapeutics, which will collaborate with Samsung Bioepis across a number of areas, including clinical development, regulatory registration and commercialization in China. Samsung Bioepis will receive an upfront payment, as well as royalties on sales. Additional financial details were not disclosed. 

Carlistbid.My Steps Up With 2nd Inspection Hub

SHAH ALAM, Feb 11 (Bernama) --, a brand under has just opened their 2nd inspection hub here in 3 Stone Park, Glenmarie, to cater to the increasing demand for cars through their auction platform. This hub’s main benefit is that it can store up to 200 cars at any given time, as well as inspect, register and conduct car transactions.

With a simple and effortless process to sell your car, the seller submits their vehicle information details, then they will be contacted to arrange a physical 100-point vehicle inspection. Once the evaluation is done, a reserve price will be agreed before the online auction is conducted.

Harry Potter: Hogwarts Mystery Brings New Choices, Challenges and Couture with February Sidequest, the Celestial Ball

LOS ANGELES, Feb 11 (Bernama) --

Jam City:

Jam City, a Los Angeles-based mobile games studio, in partnership with Warner Bros. Interactive Entertainment’s Portkey Games, a label dedicated to creating new Wizarding World mobile and videogame experiences that place the player at the center of their own adventure, inspired by J.K. Rowling’s original stories.

This February, in the mobile game, Harry Potter: Hogwarts Mystery, Hogwarts is abuzz with the social event of the season – the Celestial Ball! In this special adventure, fourth-year players and above can participate in the after-class planning and preparations for this first formal dance. Maneuvering a host of choices and social situations, players will partner with their peers in an effort to make the event a resounding, resplendent success!

AmBank Group Wins Award For Best SME Bank

KUALA LUMPUR, Feb 11 (Bernama) -- AmBank Group has been named the Best SME Bank award for Malaysia by Global Banking & Finance Review. Global Banking & Finance Review is a leading UK based financial portal and Print Magazine offering News, Analysis, Opinion, Reviews, Interviews and Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax and Legal, Islamic Finance, Asset and Wealth Management.

Commenting on the award win, Dato’ Sulaiman Mohd Tahir, Group Chief Executive Officer, AmBank Group said, “We are very honoured to receive this award for the very first time. This achievement bears testament to our commitment for excellence and the support rendered to our SME clients which has resulted in their continued trust.”

RM9.4 Million Penalty Imposed On MyEG For Infringing The Competition Act 2010

KUALA LUMPUR, Feb 8 (Bernama) -- The Malaysia Competition Commission (“MyCC”) wishes to state on record that as of the date of this press release, MyEG has continuously been in non-compliance with the decision of the Competition Appeal Tribunal (“CAT”) dated 28 December 2018 which affirmed MyCC’s decision dated 24 June 2016 (“CAT Decision”).

Upon the dismissal of MyEG’s Judicial Review application by the High Court on 22 January 2019, MyCC has instructed its solicitors to demand compliance with the remedial orders as set out in paragraphs 58 (iii) and 58 (iv) of the CAT Decision and for the payment of the daily penalty. The daily penalty of RM7,500.00 will continue to accumulate until compliance by MyEG with the directives imposed by the CAT in paragraph 58 of the CAT Decision. The total financial penalty, to date, has accumulated to RM9,464,700.00.